(Q44511393)

English

Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Schleuning M

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Günther W

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Tischer J

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ledderose G

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kolb HJ

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

243-250

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704135

0 references

Trial of IFN or STI571 before proceeding to allografting for CML?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

21 January 2018

Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

21 January 2018

Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

21 January 2018

A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

21 January 2018

The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

21 January 2018

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

21 January 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

21 January 2018

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithymocyte serum and methotrexate for control of graft-versus-host disease in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704135

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704135

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44511393&oldid=1465409456"